Your browser doesn't support javascript.
loading
Association between germline variants and somatic mutations in colorectal cancer.
Barfield, Richard; Qu, Conghui; Steinfelder, Robert S; Zeng, Chenjie; Harrison, Tabitha A; Brezina, Stefanie; Buchanan, Daniel D; Campbell, Peter T; Casey, Graham; Gallinger, Steven; Giannakis, Marios; Gruber, Stephen B; Gsur, Andrea; Hsu, Li; Huyghe, Jeroen R; Moreno, Victor; Newcomb, Polly A; Ogino, Shuji; Phipps, Amanda I; Slattery, Martha L; Thibodeau, Stephen N; Trinh, Quang M; Toland, Amanda E; Hudson, Thomas J; Sun, Wei; Zaidi, Syed H; Peters, Ulrike.
Afiliación
  • Barfield R; Department of Biostatistics and Bioinformatics, Duke University, 11028A Hock Plaza, 2424 Erwin Road Suite 1106, Durham, NC, 27705, USA. richard.barfield@duke.edu.
  • Qu C; Public Health Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
  • Steinfelder RS; Public Health Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
  • Zeng C; National Human Genome Research Institute, National Institutes of Health, Bethesda, MD, USA.
  • Harrison TA; Public Health Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
  • Brezina S; Institute of Cancer Research, Department of Medicine I, Medical University Vienna, Vienna, Austria.
  • Buchanan DD; Colorectal Oncogenomics Group, Department of Clinical Pathology, The University of Melbourne, Parkville, VIC, 3010, Australia.
  • Campbell PT; University of Melbourne Centre for Cancer Research, Victorian Comprehensive Cancer Centre, Parkville, VIC, 3010, Australia.
  • Casey G; Genomic Medicine and Family Cancer Clinic, The Royal Melbourne Hospital, Parkville, VIC, Australia.
  • Gallinger S; Department of Epidemiology and Population Science, Albert Einstein College of Medicine, Bronx, NY, USA.
  • Giannakis M; Center for Public Health Genomics, University of Virginia, Charlottesville, VA, USA.
  • Gruber SB; Lunenfeld Tanenbaum Research Institute, Mount Sinai Hospital, University of Toronto, Toronto, ON, Canada.
  • Gsur A; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA, USA.
  • Hsu L; The Broad Institute of MIT and Harvard, Cambridge, MA, USA.
  • Huyghe JR; Department of Medical Oncology and Therapeuytic, University of Southern California, Los Angeles, CA, USA.
  • Moreno V; Institute of Cancer Research, Department of Medicine I, Medical University Vienna, Vienna, Austria.
  • Newcomb PA; Public Health Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
  • Ogino S; Department of Biostatistics, University of Washington, Seattle, WA, USA.
  • Phipps AI; Public Health Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
  • Slattery ML; Oncology Data Analytics Program, Catalan Institute of Oncology-IDIBELL, L'Hospitalet de Llobregat, Barcelona, Spain.
  • Thibodeau SN; CIBER Epidemiología Y Salud Pública (CIBERESP), Madrid, Spain.
  • Trinh QM; Department of Clinical Sciences, Faculty of Medicine, University of Barcelona, Barcelona, Spain.
  • Toland AE; ONCOBEL Program, Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet de Llobregat, Barcelona, Spain.
  • Hudson TJ; Public Health Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
  • Sun W; School of Public Health, University of Washington, Seattle, WA, USA.
  • Zaidi SH; The Broad Institute of MIT and Harvard, Cambridge, MA, USA.
  • Peters U; Program in MPE Molecular Pathological Epidemiology, Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
Sci Rep ; 12(1): 10207, 2022 06 17.
Article en En | MEDLINE | ID: mdl-35715570
ABSTRACT
Colorectal cancer (CRC) is a heterogeneous disease with evidence of distinct tumor types that develop through different somatically altered pathways. To better understand the impact of the host genome on somatically mutated genes and pathways, we assessed associations of germline variations with somatic events via two complementary approaches. We first analyzed the association between individual germline genetic variants and the presence of non-silent somatic mutations in genes in 1375 CRC cases with genome-wide SNPs data and a tumor sequencing panel targeting 205 genes. In the second analysis, we tested if germline variants located within previously identified regions of somatic allelic imbalance were associated with overall CRC risk using summary statistics from a recent large scale GWAS (n≃125 k CRC cases and controls). The first analysis revealed that a variant (rs78963230) located within a CNA region associated with TLR3 was also associated with a non-silent mutation within gene FBXW7. In the secondary analysis, the variant rs2302274 located in CDX1/PDGFRB frequently gained/lost in colorectal tumors was associated with overall CRC risk (OR = 0.96, p = 7.50e-7). In summary, we demonstrate that an integrative analysis of somatic and germline variation can lead to new insights about CRC.
Asunto(s)

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias Colorrectales / Mutación de Línea Germinal Tipo de estudio: Risk_factors_studies Límite: Humans Idioma: En Revista: Sci Rep Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias Colorrectales / Mutación de Línea Germinal Tipo de estudio: Risk_factors_studies Límite: Humans Idioma: En Revista: Sci Rep Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos